 Q BioMed Inc has outlined its strategic directions and goals for 2022 that call for increasing revenues as the biotech seeks to monetize its current pipeline of products and platforms. From inception our goal has been to identify assets and advance them to a point where they can return value to our shareholders, the company said in a statement. 